SIGNIFICANCE OF THE T(1418) TRANSLOCATION AND BCL-2 GENE DEREGULATION IN NON-HODGKINS-LYMPHOMA

被引：0
|
作者：
MCDONNELL, TJ
机构：
来源：
DIAGNOSTIC ONCOLOGY | 1994年 / 4卷 / 01期
关键词：
BCL-2; ONCOGENE; APOPTOSIS; LYMPHOMA; CHROMOSOMAL TRANSLOCATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The bcl-2 proto-oncogene was discovered by cloning the t(14;18)(q32;q21) translocation breakpoint seen in most follicular lymphomas. However, bcl-2 may be highly expressed in the absence of the t(14;18) so that assessment of its prognostic significance must be based on gene expression as well as cytogenetics. The bcl-2 oncogene is unique in its ability to extend cellular viability by overriding programmed cell death without augmenting cellular proliferation. Therapeutic interventions are now being implemented to induce programmed cell death in lymphoid malignancies.
引用
收藏
页码：18 / 21
页数：4
相关论文
共 50 条
  • [21] T-CELL NON-HODGKINS-LYMPHOMA OF THE LUNG
    MAEJIMA, S
    KITANO, K
    ICHIKAWA, S
    KANEKO, T
    SAITO, H
    KIYOSAWA, K
    FURUTA, S
    INTERNAL MEDICINE, 1993, 32 (05) : 403 - 407
  • [22] Prognostic significance of Bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
    Gascoyne, RD
    Adomat, SA
    Krajewski, S
    Krajewska, M
    Horsman, DE
    Tolcher, AW
    OReilly, SE
    Hoskins, P
    Coldman, AJ
    Reed, JC
    Connors, JM
    BLOOD, 1997, 90 (01) : 244 - 251
  • [23] INCIDENCE OF EPSTEIN-BARR-VIRUS BCL-2 EXPRESSION AND CHROMOSOMAL TRANSLOCATION T(1418) IN LARGE-CELL LYMPHOMA ASSOCIATED WITH PARAGRANULOMA (LYMPHOCYTE-PREDOMINANT HODGKINS-DISEASE)
    HANSMANN, ML
    SHIBATA, D
    LORENZEN, J
    HELL, K
    NATHWANI, BN
    FISCHER, R
    HUMAN PATHOLOGY, 1994, 25 (03) : 240 - 243
  • [24] SIGNIFICANCE OF CLINICAL AND BIOCHEMICAL PARAMETERS FOR COURSE AND PROGNOSIS OF NON-HODGKINS-LYMPHOMA
    STEINKE, B
    MAU, J
    KLINISCHE WOCHENSCHRIFT, 1986, 64 (10): : 445 - 451
  • [25] CLINICAL-SIGNIFICANCE OF HEMATOLOGIC PARAMETERS IN NON-HODGKINS-LYMPHOMA AT DIAGNOSIS
    CONLAN, MG
    ARMITAGE, JO
    BAST, M
    WEISENBURGER, DD
    CANCER, 1991, 67 (05) : 1389 - 1395
  • [26] P53, BCL-2 AND KI-67 EXPRESSION IN 86 CONSECUTIVE CASES OF GASTROINTESTINAL NON-HODGKINS-LYMPHOMA (NHL)
    GISBERTZ, IAM
    ARENDS, JW
    SCHOUTEN, HC
    BLOOD, 1994, 84 (10) : A444 - A444
  • [27] STAGE 1 AND 2 NODAL NON-HODGKINS-LYMPHOMA
    DICKIE, GJ
    ROBERTS, SJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 143 - 143
  • [28] P53 MUTATIONS, C-MYC AND BCL-2 REARRANGEMENTS IN HUMAN NON-HODGKINS-LYMPHOMA CELL-LINES
    CHANG, H
    BLONDAL, JA
    BENCHIMOL, S
    MINDEN, MD
    MESSNER, HA
    LEUKEMIA & LYMPHOMA, 1995, 19 (1-2) : 165 - 171
  • [29] Significance of Bcl-2 and Bcl-6 immunostaining in Non Hodgkin's lymphoma
    Mahmoud, Hanan Mohamed
    El-Sakhawy, Yasmin Nabil
    HEMATOLOGY REPORTS, 2011, 3 (03) : 80 - 85
  • [30] 2-CHLORODEOXYADENOSINE THERAPY IN NON-HODGKINS-LYMPHOMA
    BOSLY, A
    FERRANT, A
    DELANNOY, A
    CHATELAIN, C
    MARTIAT, P
    CORNU, G
    MINEUR, P
    DOYEN, C
    ZENEBERGH, A
    MICHAUX, JL
    BLOOD, 1993, 82 (10) : A560 - A560
12345